IceCure Medical (NASDAQ:ICCM – Get Free Report) and Cooper Companies (NASDAQ:COO – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings and risk.
Institutional and Insider Ownership
0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares IceCure Medical and Cooper Companies”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| IceCure Medical | $3.38 million | 2.24 | -$15.06 million | ($8.52) | -0.26 |
| Cooper Companies | $4.09 billion | 2.50 | $374.90 million | $2.93 | 18.40 |
Cooper Companies has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and recommmendations for IceCure Medical and Cooper Companies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| IceCure Medical | 2 | 0 | 3 | 0 | 2.20 |
| Cooper Companies | 2 | 11 | 5 | 0 | 2.17 |
IceCure Medical currently has a consensus target price of $52.50, suggesting a potential upside of 2,275.57%. Cooper Companies has a consensus target price of $71.47, suggesting a potential upside of 32.57%. Given IceCure Medical’s stronger consensus rating and higher probable upside, research analysts plainly believe IceCure Medical is more favorable than Cooper Companies.
Risk & Volatility
IceCure Medical has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500. Comparatively, Cooper Companies has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500.
Profitability
This table compares IceCure Medical and Cooper Companies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| IceCure Medical | -427.67% | -174.26% | -112.58% |
| Cooper Companies | 13.46% | 10.90% | 7.24% |
Summary
Cooper Companies beats IceCure Medical on 11 of the 14 factors compared between the two stocks.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
About Cooper Companies
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.
